Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2026)

Rigel Pharmaceuticals' Inventory Average history runs 9 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• In Q1 2026, Inventory Average rose 117.22% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $11.6 million (up 117.22% YoY), while the FY2025 annual figure was $8.8 million, up 51.93% from the prior year.
• Inventory Average was $11.6 million for Q1 2026 at Rigel Pharmaceuticals, down from $12.4 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $12.4 million in Q4 2025 to a low of $5.3 million in Q1 2025.
• Historically, Inventory Average has averaged $8.1 million across 5 years, with a median of $7.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory Average tumbled 40.08% in 2024, then jumped 130.01% in 2025.
• A 5-year view of Inventory Average shows it stood at $8.1 million in 2022, then retreated by 28.34% to $5.8 million in 2023, then decreased by 7.29% to $5.4 million in 2024, then surged by 130.01% to $12.4 million in 2025, then dropped by 6.65% to $11.6 million in 2026.
• The last three Inventory Average figures came in at $11.6 million (Q1 2026), $12.4 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.